Oxehealth
Company Bio
For those with mental health and behavioral health facilities:
Oxehealth has developed the first AI-powered patient monitoring platform for mental/behavioral health facilities - intelligent, secure and completely contact-free. Born out of Oxford University and co-developed by patients and clinicians to deliver safer, higher quality, more efficient care.
It provides clinicians with increased visibility and awareness of patients. This enhances their ability to assess and respond to patient needs by providing real-time insights into changes in clinical risk, enabling earlier interventions. The platform continuously monitors patient activity, sleep patterns and vital signs, offering personalised data to support recovery and improve outcomes.
By shifting towards proactive care, it reduces administrative burden, allowing staff to focus more on patient care. The system includes two Class II FDA-cleared medical devices and has supported over 70 million hours of patient care globally. Peer-reviewed and real-world evidence demonstrates its effectiveness in reducing patient incidents and harm while improving the quality and staff efficiency of inpatient care.
For those without mental health and behavioral health facilities:
Oxehealth has developed the first AI-powered patient monitoring platform for inpatient facilities that is intelligent, secure and completely contact-free. Born out of Oxford University and co-developed by patients and clinicians to deliver safer, higher quality, more efficient care across a range of care environments.
It provides clinicians with increased visibility and awareness of patients. This enhances their ability to assess and respond to patient needs by providing real-time insights into changes in clinical risk, enabling earlier interventions. The platform continuously monitors patient activity, sleep patterns and vital signs, offering personalised data to support recovery and improve outcomes.
By shifting towards proactive care, it reduces administrative burden, allowing staff to focus more on direct patient care. The system includes two Class II FDA-cleared medical devices and has supported over 70 million hours of patient care globally. Peer-reviewed evidence demonstrates its effectiveness in reducing adverse events while improving the quality and staff efficiency of inpatient care.
